Elan Corporation PLC Names Ex-GlaxoSmithKline CEO Robert Ingram Chairman, Replacing McLaughlin

Published: Dec 06, 2010

Bloomberg -- Elan Corp. Plc, under pressure from activist shareholder Ib Sonderby, named Robert Ingram chairman to replace Kyran McLaughlin after voters at the company’s annual general meeting opposed his re-election.

Back to news